4
Changes in Ownership
Kalaris Therapeutics, Inc. Filed Acc 0000950170-24-018785
Chief Executive Officer sold 8,252 shares at an average $0.70 ($5,803)
From the SEC's structured data for this filing
Trades in this filing
Brainard Diana · Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-02-20 | Sale : show line 1 in the form | −3,097 | $0.70 | $2,153 | 819,224 | D |
| 2024-02-21 | Sale : show line 2 in the form | −5,155 | $0.71 | $3,650 | 814,069 | D |
| Open-market sales · 8,252 sh · avg $0.70 · $5,803 | ||||||
Loading xslF345X05/ownership.xml…